SMTL ID : 2win.2 (1 other biounit)

C3 convertase (C3bBb) stabilized by SCIN

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.90 Å

Oligo State

hetero-2-2-2-2-mer

Ligands

1 x NAG- NAG- BMA- BMA- BMA: beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-BMA-BMA.1: 5 residues within 4Å: Chain A: T.19, N.63, L.479, K.480, A.481 No protein-ligand interaction detected (PLIP)

2 x NAG- NAG- BMA- BMA: beta-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-BMA.2: 2 residues within 4Å: Chain A: N.178 Chain B: N.191 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA-BMA.3: 3 residues within 4Å: Chain C: N.63, K.480, A.481 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- BMA- BMA- BMA- BMA: beta-D-mannopyranose-(1-3)-[beta-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-BMA-BMA-BMA.4: 3 residues within 4Å: Chain C: P.148, N.178 Chain D: N.191 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-MAN.5: 3 residues within 4Å: Chain E: S.25, N.26, G.29 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.6: 3 residues within 4Å: Chain E: W.118, N.119, N.158 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-MAN-MAN-MAN.7: 7 residues within 4Å: Chain F: I.22, S.25, N.26, P.173, V.196, E.200 Ligands: BMA.10 1 PLIP interactions: 1 interactions with chain F Hydrogen bonds: F:E.200

2 x MG: MAGNESIUM ION(Non-covalent)

MG.8: 6 residues within 4Å: Chain B: N.915 Chain E: S.19, S.21, S.92, T.94, L.132 5 PLIP interactions: 3 interactions with chain E, 2 Ligand-Water interactions Metal complexes: E:S.19, E:S.21, E:T.94, H2O.1, H2O.1 MG.9: 6 residues within 4Å: Chain D: N.915 Chain F: S.19, S.21, S.92, T.94, L.132 5 PLIP interactions: 3 interactions with chain F, 2 Ligand-Water interactions Metal complexes: F:S.19, F:S.21, F:T.94, H2O.1, H2O.1

1 x BMA: beta-D-mannopyranose(Non-functional Binders)

BMA.10: 1 residues within 4Å: Ligands: NAG-NAG-MAN-MAN-MAN.7 No protein-ligand interaction detected (PLIP)

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.11: 2 residues within 4Å: Chain F: N.119, R.120 1 PLIP interactions: 1 interactions with chain F Hydrophobic interactions: F:R.120

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rooijakkers, S.H. et al., Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor. Nat. Immunol. (2009)

Release Date

2009-06-09

Peptides

COMPLEMENT C3 BETA CHAIN: AC
COMPLEMENT C3B ALPHA' CHAIN: BD
COMPLEMENT FACTOR B: EF
STAPHYLOCOCCAL COMPLEMENT INHIBITOR: GH

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

C
E

B
D

D
F

E
I

F
K

G
M

H
P

COMPLEMENT C3 BETA CHAIN

COMPLEMENT C3B ALPHA' CHAIN

COMPLEMENT FACTOR B

STAPHYLOCOCCAL COMPLEMENT INHIBITOR

Related Entries With Identical Sequence